|  | 2013–2014 | 2015–2016 | 2017–2018 |
---|---|---|---|---|
Patients | Â | 108 | 131 | 93 |
Rate of LN-RT | Â | 25.0% | 35.1% | 40.9% |
Rate of IMRT/VMAT use |  Total (n = 332) | 5.6% | 21.4% | 80.7% |
 |  Treatment with LN-RT (n = 111) | 22.2% | 43.5% | 94.7% |
 |  Treatment without LN-RT (n = 221) | 0.0% | 9.4% | 70.9% |